MedTrace Logo

Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy

NCT01711892 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2014-04-21

No results posted yet for this study

Summary

Androgen Deprivation Therapy (ADT) is standard treatment for locally advanced or advanced Prostate Cancer (PC).

The musculoskeletal toxicity associated with ADT is well established, leading to a decrease in muscle mass, increased fat percentage, weight gain, sexual dysfunction and increased risk of depression, fatigue, diabetes, cardiovascular disease and reduced quality of life.

Numerous studies have shown an association between physical activity, physical capacity and quality of life in cancer patients and recent epidemiological research suggest that regular, moderate-intensity physical activity may have a positive effect on survival in men with prostate cancer.

Within exercise physiology there is new evidence pointing to recreational soccer as a unique form of intermittent exercise that effectively stimulates aerobic and anaerobic energy delivery systems, leading to beneficial musculoskeletal, metabolic and cardiovascular adaptations of importance for health.

It is our overall hypothesis that 12 weeks of recreational soccer training 2-3 times per week will improve the health profile of PC patients receiving ADT treatment.

Conditions

  • Prostatic Neoplasms
  • Exercise
  • Soccer Training
  • Androgen Deprivation Therapy

Interventions

BEHAVIORAL

Soccer training

Sponsors & Collaborators

  • Danish Cancer Society

    collaborator OTHER

  • Novo Nordisk A/S

    collaborator INDUSTRY

  • TrygFonden, Denmark

    collaborator INDUSTRY

  • Beckett Foundation

    collaborator OTHER

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Mikael Rørth, Professor · University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01711892 on ClinicalTrials.gov